Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Upcoming)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI115146

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

M Mukoyama, K Nakao, K Hosoda, S Suga, Y Saito, Y Ogawa, G Shirakami, M Jougasaki, K Obata, and H Yasue

Department of Medicine, Kyoto University School of Medicine, Japan.

Find articles by Mukoyama, M. in: JCI | PubMed | Google Scholar

Department of Medicine, Kyoto University School of Medicine, Japan.

Find articles by Nakao, K. in: JCI | PubMed | Google Scholar

Department of Medicine, Kyoto University School of Medicine, Japan.

Find articles by Hosoda, K. in: JCI | PubMed | Google Scholar

Department of Medicine, Kyoto University School of Medicine, Japan.

Find articles by Suga, S. in: JCI | PubMed | Google Scholar

Department of Medicine, Kyoto University School of Medicine, Japan.

Find articles by Saito, Y. in: JCI | PubMed | Google Scholar

Department of Medicine, Kyoto University School of Medicine, Japan.

Find articles by Ogawa, Y. in: JCI | PubMed | Google Scholar

Department of Medicine, Kyoto University School of Medicine, Japan.

Find articles by Shirakami, G. in: JCI | PubMed | Google Scholar

Department of Medicine, Kyoto University School of Medicine, Japan.

Find articles by Jougasaki, M. in: JCI | PubMed | Google Scholar

Department of Medicine, Kyoto University School of Medicine, Japan.

Find articles by Obata, K. in: JCI | PubMed | Google Scholar

Department of Medicine, Kyoto University School of Medicine, Japan.

Find articles by Yasue, H. in: JCI | PubMed | Google Scholar

Published April 1, 1991 - More info

Published in Volume 87, Issue 4 on April 1, 1991
J Clin Invest. 1991;87(4):1402–1412. https://doi.org/10.1172/JCI115146.
© 1991 The American Society for Clinical Investigation
Published April 1, 1991 - Version history
View PDF
Abstract

Using a specific radioimmunoassay for human brain natriuretic peptide (hBNP) with a monoclonal antibody, we have investigated its synthesis, secretion, and clearance in comparison with those of atrial natriuretic peptide (ANP) in normal subjects and patients with congestive heart failure (CHF). Mean BNP-like immunoreactivity (-LI) levels in normal atrium and ventricle were 250 and 18 pmol/g, respectively. The plasma BNP-LI level in normal subjects was 0.90 +/- 0.07 fmol/ml, which was 16% of the ANP-LI level. In contrast, the plasma BNP-LI level markedly increased in patients with CHF in proportion to its severity, and surpassed the ANP-LI level in severe cases. There was a significant step-up of the plasma BNP-LI level in the coronary sinus (CS) compared with that in the aortic root (Ao) and the difference between these BNP-LI levels, delta(CS-Ao)BNP, also increased with the severity of CHF. In addition, the step-up of the BNP-LI level in the anterior interventricular vein [delta(AIV-Ao)BNP] was comparable to delta(CS-Ao)BNP, indicating that BNP is secreted mainly from the ventricle. Predominant BNP synthesis in the ventricle was also confirmed by Northern blot analysis. Catheterization and pharmacokinetic studies revealed that hBNP is cleared from the circulation more slowly than alpha-hANP; this was in part attributed to lower (about 7%) binding affinity of hBNP to clearance receptors than that of alpha-hANP. A predominant molecular form of BNP-LI in the heart and plasma was a 3-kD form corresponding to hBNP. These results indicate that BNP is a novel cardiac hormone secreted predominantly from the ventricle, and that the synthesis, secretion and clearance of BNP differ from those of ANP, suggesting discrete physiological and pathophysiological roles of BNP in a dual natriuretic peptide system.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1402
page 1402
icon of scanned page 1403
page 1403
icon of scanned page 1404
page 1404
icon of scanned page 1405
page 1405
icon of scanned page 1406
page 1406
icon of scanned page 1407
page 1407
icon of scanned page 1408
page 1408
icon of scanned page 1409
page 1409
icon of scanned page 1410
page 1410
icon of scanned page 1411
page 1411
icon of scanned page 1412
page 1412
Version history
  • Version 1 (April 1, 1991): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts